Takasugi H | New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
スポンサーリンク
概要
関連著者
-
高杉 寿
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Takasugi H
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd
-
Takasugi H
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
高杉 寿
New Drug Research Laboratories Fujisawa Pharmaceutical Co., Ltd.,
-
久野 敦司
New Drug Research Laboratories Fujisawa Pharmaceutical Co., Ltd.,
-
西野 重孝
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Nishino S
Fujisawa Pharmaceutical Co. Ltd. Osaka Jpn
-
久野 敦司
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
伊藤 清隆
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
酒井 裕義
New Drug Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.,
-
西野 重孝
New Drug Research Laboratories
-
酒井 裕義
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
大久保 充
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
杉山 良恵
New Drug Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.,
-
加藤 眞行
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
杉山 良恵
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Sakai H
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
山国 尚志
New Drug Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.,
-
田中 明人
New Drug Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.,
-
元山 行雄
New Drug Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.,
-
山国 尚志
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
元山 行雄
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
田中 明人
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
桂 洋介
New Drung Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.,
-
勝田 清貴
New Drug Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.,
-
井上 善一
New Drug Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.,
-
桂 洋介
New Drung Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
加藤 昌子
Div. Of Chemistry Fac. And Graduate School Of Sci. Hokkaido Univ.
-
井上 善一
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
勝田 清貴
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Kato M
Department Of Pharmacotherapeutics Showa Pharmaceutical University
-
Kako M
Suzuka Univ. Medical Sci. And Technol. Mie Jpn
-
友井 正明
Product Development Laboratories
-
友井 正明
Product Development Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
伊藤 立信
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
仲西 功
Molecular Design Group Fujisawa Pharmaceutical Co., Ltd.,
-
仲西 功
R & D Information, Fujisawa Pharmaceutical Co., Ltd.,
-
杉山 好恵
New Drug Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.,
-
冨士 哲男
New Drug Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.,
-
石川 弘文
New Drug Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.,
-
石川 弘文
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
NISHINO Shigetaka
New Drug Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
石川 貴敏
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
冨士 哲男
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
上谷 利治
New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
仲西 功
Molecular Design Group Fujisawa Pharmaceutical Co. Ltd.
-
Nakanishi Isao
New Drug Research Laboratories R & D Information Fujisawa Pharmaceutical Co. Ltd.
著作論文
- Studies on Cerebral Protective Agents. VIII. Synthesis of 2-Aminothiazoles and 2-Thiazolecarboxamides with Anti-anoxic Activity
- Studies on Cerebral Protective Agents. VII. Synthesis of Novel 4-Arylazole Derivatives with Anti-anoxic Activity
- Studies on Cerebral Protective Agents. VI.Synthesis of Novel 4-(4-Nitrobenzoyl)pyrimidine and Related Compounds with Anti-anoxic Activity
- Studies on Cerebral Protective Agents. V.Novel 4-(3-Nitrophenyl)pyridine and 4-(3-Nitrophenyl)pyrimidine Derivatives with Anti-anoxic Activity
- Studies on Cerebral Protective Agents. III. Novel 4-Arylpyrimidine Derivatives with Anti-anoxic and Anti-lipid Peroxidation Activities. (3)
- Studies on antiulcer Drugs. VI. 4-Furyl-2-guanidinothiazoles and Related Compounds as Potent Histamine H_2-Receptor Antagonists
- New 5-HT_3 (Serotonin-3) Receptor Antagonists. V. Synthesis and Structure-Activity Relationships of Pyrrolo[2,1-c][1,4]benzoxazine-6-carboxamides
- New 5-HT_3 (Serotonin-3) Receptor Antagonists. IV. Synthesis and Structure-Activity Relationships of Azabicycloalkaneacetamide Derivatives
- New 5-HT_3 (Serotonin-3) Receptor Antagonists. III. An Efficient Synthesis of Carbon 14-Labeled (+)-8,9-Dihydro-10-methyl-7-[(5-methyl-1H-imidazol-4-yl)methyl]pyrido[1,2-a]indol-6(7H)-one Hydrochloride (FK 1052)
- New 5-HT_3 (Serotonin-3) Receptor Antagonists. II. Synthesis and Structure-Activity Relationships of Pyrimido[1,6-α]indoles
- New 5-HT_3 (Serotonin-3) Receptor Antagonists. I. Synthesis and Structure-Activity Relationships of Pyrido[1,2-α]indoles
- Studies on Anti-platelet Agents. II. Synthesis and Platelet-Inhibitory Activity of 5-Methyl-4-(3-pyridyl)-2-(substituted Benzimidazol-5-yl)imidazoles
- Studies on Antiplatelet Agents. I. Synthesis and Platelet Inhibitory Activity of 5-Alkyl-2-aryl-4-pyridylimidazoles
- Studies on Antiulcer Drugs. V. Synthesis and Antiulcer Activity of Aralkylbenzazoles
- Studies on Antiulcer Drugs. IV. Synthesis and Antiulcer Activities of Imidazo[1,2-α]pyridinyl-ethylbenzothiazoles and -benzimidazoles
- Studies on Anti-platelet Agents. V. Synthesis and Structure-Activity Relationship of 3-Substituted 5,6-Bis(4-methoxyphenyl)-1,2,4-triazines
- Studies on Cerebral Protective Agents. II. Novel 4-Arylphrimidine Derivatives with Anti-anoxic and Anti-lipid Peroxidation Activities. (2)
- Studies on Cerebral Protective Agents. I. Novel 4-Arylpyrimidine Derivatives with Anti-anoxic and Anti-lipid Peroxidation Activities
- Studies on Cerebral Protective Agents. IV.Synthesis of Novel 4-Arylpyridine and 4-Arylpyridazine Derivatives with Anti-anoxic Activity
- Studies on Anti-platelet Agents. IV. A Series of 2-Substituted 4,5-Bis(4-methoxyphenyl)pyrimidines as Novel Anti-platelet Agents